Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Dyslipidemia is associated with a prothrombotic phenotype; however, the mechanisms responsible for enhanced platelet reactivity remain unclear. Proatherosclerotic lipid abnormalities are associated with both enhanced oxidant stress and the generation of biologically active oxidized lipids, including potential ligands for the scavenger receptor CD36, a major platelet glycoprotein. Using multiple mouse in vivo thrombosis models, we now demonstrate that genetic deletion of Cd36 protects mice from hyperlipidemia-associated enhanced platelet reactivity and the accompanying prothrombotic phenotype. Structurally defined oxidized choline glycerophospholipids that serve as high-affinity ligands for CD36 were at markedly increased levels in the plasma of hyperlipidemic mice and in the plasma of humans with low HDL levels, were able to bind platelets via CD36 and, at pathophysiological levels, promoted platelet activation via CD36. Thus, interactions of platelet CD36 with specific endogenous oxidized lipids play a crucial role in the well-known clinical associations between dyslipidemia, oxidant stress and a prothrombotic phenotype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Platelet hyperreactivity and thrombosis risk are enhanced in the setting of numerous conditions associated with atherosclerotic heart disease, such as hyperlipidemia, oxidant stress, and hyperglycemia (Podrez et al., 2007; Chen et al., 2008; Zhu et al., 2012a).”
From Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk (2016) · cites this paper as Podrez et al., 2007
Citations
Cites
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394 · cited 1×
“Because anti-inflammatory and antioxidant effects of HDL are well documente”
BackgroundFebbraio, M., Hajjar, D. P., & Silverstein, R. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14006 · Cited by 1,193 · cited 1×
“CD36 is implicated in a variety of pathological conditions, including atherosclerosis, diabetes and innate immunit”
BackgroundSelf-citationFebbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P., Hazen, S. L., Hoff, H. F., Sharma, K., & Silverstein, R. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9259 · Cited by 1,044 · cited 1×
“Absence of CD36 in a mouse model of atherogenesis results in significant inhibition of atherosclerosi”
BackgroundSelf-citationCirculating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E
Huo, Y., Schober, A., Forlow, S. B., Smith, D. F., Hyman, M. C., Jung, S., Littman, D. R., Weber, C., & Ley, K. (2003) · Nature Medicine · doi:10.1038/nm810 · Cited by 1,005 · cited 1×
“Platelet P-selectin mediates the formation of platelet-monocyte aggregates, which have been implicated in several vascular disease processe”
BackgroundCD36 is a sensor of diacylglycerides
Hoebe, K., Georgel, P., Rutschmann, S., Du, X., Mudd, S., Crozat, K., Sovath, S., Shamel, L., Hartung, T., Zähringer, U., et al. (2005) · Nature · doi:10.1038/nature03253 · Cited by 873 · cited 1×
“To address any potential issues related to the mixed genetic background of the Cd36 −/− and Apoe −/− Cd36 −/− mice, we used independently generated, CD36-deficient 'oblivious' mic”
MethodWatson, A. D., Leitinger, N., Navab, M., Faull, K. F., Hörkkö, S., Witztum, J. L., Palinski, W., Schwenke, D., Salomon, R. G., Sha, W., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13597 · Cited by 753
Self-citationCD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism
André, P., Prasad, K. S. S., Denis, C. V., He, M., Papalia, J. M., Hynes, R. O., Phillips, D. R., & Wagner, D. D. (2002) · Nature Medicine · doi:10.1038/nm0302-247 · Cited by 726
Platelet Function in Hyperlipoproteinemia
Carvalho, A. C. A., Colman, R. W., & Lees, R. S. (1974) · New England Journal of Medicine · doi:10.1056/nejm197402212900805 · Cited by 679
Platelet Hyperreactivity and Prognosis in Survivors of Myocardial Infarction
Trip, M. D., Cats, V. M., van Capelle, F. J. L., & Vreeken, J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222201 · Cited by 617
Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
Podrez, E. A., Schmitt, D., Hoff, H. F., & Hazen, S. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5549 · Cited by 492
Self-citation
Cited by
Items 101–200 of 513
Platelet-monocyte aggregates: molecular mediators of thromboinflammation
Rolling, C. C., Barrett, T. J., & Berger, J. S. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.960398 · Cited by 102
Nergiz‐Unal, R., Lamers, M. M. E., van Kruchten, R., Luiken, J. J. F. P., Cosemans, J. M. E. M., Glatz, J. F. C., Kuijpers, M. J. E., & Heemskerk, J. W. M. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04416.x · Cited by 86
Bao, Y., Wang, L., Xu, Y., Yang, Y., Wang, L., Si, S., Cho, S., & Hong, B. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.006 · Cited by 92
“Recently, CD36 on macrophages and platelets has been reported to mediate related signaling pathways linking hyperlipidemia and inflammation [49,50].”
BackgroundMass spectrometry of peptides and proteins from human blood.
Zhu, P., Bowden, P., Zhang, D., & Marshall, J. G. (2011) · Mass spectrometry reviews (Print) · doi:10.1002/mas.20291 · Cited by 70
Stübiger, G., Aldover‐Macasaet, E., Bicker, W., Sobal, G., Willfort‐Ehringer, A., Pock, K., Bochkov, V. N., Widhalm, K., & Belgacem, O. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.06.010 · Cited by 93
“headgroups and fatty acid residues) is closely related to their biological actions in vivo [30].”
BackgroundThe Antithrombotic Effects of Statins
Owens, A. P., & Mackman, N. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-051812-145304 · Cited by 86
Colas, R. A., Sassolas, A., Guichardant, M., Cugnet‐Anceau, C., Moret, M., Moulin, P., Lagarde, M., & Calzada, C. (2011) · Diabetologia · doi:10.1007/s00125-011-2272-8 · Cited by 85
“More recently, the Podrez group showed that oxidised choline glycerophospholipids induce platelet aggregation via CD36 [45].”
BackgroundMorrell, C. N. (2008) · Circulation Research · doi:10.1161/circresaha.108.184325 · Cited by 82
Wraith, K. S., Magwenzi, S., Aburima, A. A., Wen, Y., Leake, D. S., & Naseem, K. M. (2013) · Blood · doi:10.1182/blood-2013-04-491688 · Cited by 81
Platelet Innate Immune Receptors and TLRs: A Double-Edged Sword
Ebermeyer, T., Cognasse, F., Berthelot, P., Mismetti, P., Garraud, O., & Hamzeh‐Cognasse, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157894 · Cited by 86
Leibundgut, G., Arai, K., Orsoni, A., Yin, H., Scipione, C., Miller, E. R., Koschinsky, M. L., Chapman, M. J., Witztum, J. L., & Tsimikas, S. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.12.033 · Cited by 80
“concert with hyperlipidemia induce platelet aggregation through a CD36 scavenger receptor pathway in platelets (22).”
BackgroundThe Role of Phospholipid Oxidation Products in Inflammatory and Autoimmune Diseases
Leitinger, N. (2008) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-8830-8_12 · Cited by 93
Min, K., Um, H. J., Cho, K., & Kwon, T. K. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.04.008 · Cited by 79
Targeting Platelet in Atherosclerosis Plaque Formation: Current Knowledge and Future Perspectives
Wang, L., & Tang, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249760 · Cited by 93
“The increased lipid in the plasma of patients with hyperlipidemia invades the intimal endothelium in the form of LDL through their receptor, and is oxidized to oxidized low-density lipoprotein (oxLDL) [34].”
BackgroundPlatelet‐Mediated Enhancement of Leukocyte Adhesion
von Hundelshausen, P., Koenen, R. R., & Weber, C. (2009) · Microcirculation · doi:10.1080/10739680802564787 · Cited by 78
“Deletion of the scavenger receptor, CD36, which binds oxidized choline glycerophospholipids, protects mice from hyperlipidemia-associated enhanced platelet reactivity [73].”
BackgroundNavarese, E. P., Kołodziejczak, M., Kereiakes, D. J., Tantry, U. S., O'Connor, C., & Gurbel, P. A. (2016) · Annals of Internal Medicine · doi:10.7326/m15-2994 · Cited by 77
Potentiation and priming of platelet activation: a potential target for antiplatelet therapy
Gresele, P., Falcinelli, E., & Momi, S. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.05.002 · Cited by 78
LNK/SH2B3 Loss of Function Promotes Atherosclerosis and Thrombosis
Wang, W., Tang, Y., Wang, Y., Tascau, L., Balcerek, J., Tong, W., Levine, R. L., Welch, C. L., Tall, A. R., & Wang, N. (2016) · Circulation Research · doi:10.1161/circresaha.116.308955 · Cited by 81
The effect of oxidized phospholipids on phenotypic polarization and function of macrophages
Serbulea, V., DeWeese, D., & Leitinger, N. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.02.035 · Cited by 74
Handberg, A., Norberg, M., Stenlund, H. C., Hallmans, G., Attermann, J., & Eriksson, J. W. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2002 · Cited by 82
Hyperlipidemia, tissue factor, coagulation, and simvastatin
Owens, A. P., Byrnes, J. R., & Mackman, N. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2013.07.003 · Cited by 85
Supporting Roles of Platelet Thrombospondin-1 and CD36 in Thrombus Formation on Collagen
Kuijpers, M. J. E., Witt, S., Nergiz‐Unal, R., van Kruchten, R., Korporaal, S. J. A., Verhamme, P. B., Febbraio, M., Tjwa, M., Voshol, P. J., Hoylaerts, M., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302917 · Cited by 79
“of oxLDL, was found to contribute to atherosclerotic lesion development(33) and hyperlipidemia-associated enhanced platelet reactivity.(12) The oxLDL–CD36 pathway is supposed to signal via the mitogen-activated protein kinases JNK,(14) and p38 mitogenactivated protein kinase,(13) and the tyrosine kinase Syk.”
BackgroundSelf-citationГрубер, Ф., Bicker, W., Oskolkova, O., Tschachler, E., & Bochkov, V. N. (2012) · Journal of Lipid Research · doi:10.1194/jlr.d025270 · Cited by 82
Mechanism of Tumor-Platelet Communications in Cancer
Dudiki, T., Veleeparambil, M., Zhevlakova, I., Biswas, S., Klein, E. A., Ford, P., Podrez, E. A., & Byzova, T. V. (2023) · Circulation Research · doi:10.1161/circresaha.122.321861 · Cited by 87
Self-citationBiswas, S., Zimman, A., Gao, D., Byzova, T. V., & Podrez, E. A. (2017) · Circulation Research · doi:10.1161/circresaha.117.311069 · Cited by 77
Self-citationMadrigal‐Matute, J., Martínez-Pinna, R., Ramos‐Mozo, P., Blanco‐Colio, L. M., Moreno, J. A., Tarín, C., Burillo, E., Fernandez‐Garcia, C. E., Egido, J., Meilhac, O., et al. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-04-0248 · Cited by 79
Yi, X., Zhou, Q., Lin, J., & Chi, L. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00929.x · Cited by 73
Lipoprotein(a), platelet function and cardiovascular disease
Bhatia, H. S., Becker, R. C., Leibundgut, G., Patel, M. P., Lacaze, P. A., Tonkin, A. M., Narula, J., & Tsimikas, S. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00947-2 · Cited by 86
“…the CD36–OxPL interaction in platelet function comes from a study using multiple in vivo mouse models of thrombosis, demonstrating that whole-body genetic deletion of Cd36 protected mice from hyperlipidaemia-associated increased platelet reactivity and the accompanying prothrombotic phenotype 26 .”
Scavenger receptor BI modulates platelet reactivity and thrombosis in dyslipidemia
Ma, Y., Ashraf, M. Z., & Podrez, E. A. (2010) · Blood · doi:10.1182/blood-2010-02-268508 · Cited by 72
Self-citationCD36 signaling in vascular redox stress
Yang, M., & Silverstein, R. L. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.02.021 · Cited by 81
Self-citationProtein lipid modifications—More than just a greasy ballast
Hentschel, A., Zahedi, R. P., & Ahrends, R. (2015) · PROTEOMICS · doi:10.1002/pmic.201500353 · Cited by 79
“Additionally, the binding of these oxidized phospholipids to the CD36 receptor of platelets induces aggregation, potentially leading to thrombosis [230].”
BackgroundStructural Identification and Cardiovascular Activities of Oxidized Phospholipids
Salomon, R. G. (2012) · Circulation Research · doi:10.1161/circresaha.112.275388 · Cited by 72
Self-citationLysophosphatidylcholine is Generated by Spontaneous Deacylation of Oxidized Phospholipids
Choi, J., Zhang, W., Gu, X., Chen, X., Hong, L., Laird, J. M., & Salomon, R. G. (2010) · Chemical Research in Toxicology · doi:10.1021/tx100305b · Cited by 74
“On platelets they promote aggregation, accounting for the prothrombotic phenotype that is linked with hyperlipidemia and oxidant stress (30).”
BackgroundSelf-citationMorgan, L. T., Thomas, C. P., Kühn, H., & O’Donnell, V. B. (2010) · Biochemical Journal · doi:10.1042/bj20100415 · Cited by 71
Platelet Activation by Low Concentrations of Intact Oxidized LDL Particles Involves the PAF Receptor
Chen, R., Chen, X., Salomon, R. G., & McIntyre, T. M. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.178731 · Cited by 75
Self-citationZhou, M.-S., Chadipiralla, K., Mendez, A. J., Jaimes, E. A., Silverstein, R. L., Webster, K. A., & Raij, L. R. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00042.2013 · Cited by 83
Self-citationBarale, C., Bonomo, K., Frascaroli, C., Morotti, A., Guerrasio, A., Cavalot, F. L., & Russo, I. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.09.012 · Cited by 74
“Multiple mechanisms are involved in the increased platelet activation [6,7] .”
Depression and Cardiovascular Disease: The Viewpoint of Platelets
Amadio, P., Zarà, M., Sandrini, L., Ieraci, A., & Barbieri, S. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207560 · Cited by 82
“In particular, by binding scavenger receptors on platelets (e.g., CD36) [228,263], oxLDL enhances NADPH oxidase-2 (NOX-2)-mediated generation of ROS and platelet hyper-reactivity [264], including platelet degranulation, GPaIIb3-integrin activation, apoptosis, thrombin generation, and shape change.”
BackgroundCD36 as a Multiple-Ligand Signaling Receptor in Atherothrombosis
Nergiz-Unal, R., Rademakers, T., M.E.M. Cosemans, J., & W.M. Heemskerk, J. (2011) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152511794182855 · Cited by 69
“The likely mechanism is binding and uptake of lipids (oxLDL) via CD36 with as result intracellular lipid accumulation [76, 79, 84, 123, 151].”
BackgroundInfluentialFerroni, P., Vazzana, N., Riondino, S., Cuccurullo, C., Guadagni, F., & Davì, G. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4324 · Cited by 68
“It has been suggested (233) that platelet CD36 might serve as a sensor of specific oxidized phospholipids generated during oxidative stress.”
Liani, R., Halvorsen, B. L., Sestili, S., Handberg, A., Santilli, F., Vazzana, N., Formoso, G., Aukrust, P., & Davì, G. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.012 · Cited by 78
“Thus, CD36 may serve to “prime” or sensitize the platelet for subsequent activation, and this may contribute to platelet hyperreactivity [9].”
BackgroundResultInfluentialYang, M., Kholmukhamedov, A., Schulte, M. L., Cooley, B. C., Scoggins, N. O., Wood, J. P., Cameron, S. J., Morrell, C. N., Jobe, S. M., & Silverstein, R. L. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018025411 · Cited by 73
“oxLDL-mediated platelet PSer exposure requires CD36 signaling through the redox sensor MAPK ERK5 CD36 is the major high-affinity platelet receptor for oxidized lipids in oxLDL particles.(2,36) In the presence of the CD36-blocking monoclonal antibody FA6-152, oxLDL-stimulated PSer exposure in human platelets was comple…”
BackgroundMethodResultInfluentialSelf-citationLipidomic insight into cardiovascular diseases
Kohno, S., Keenan, A. L., Ntambi, J. M., & Miyazaki, M. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.106 · Cited by 68
Vav guanine nucleotide exchange factors link hyperlipidemia and a prothrombotic state
Chen, K., Li, W., Major, J. A., Rahaman, S. O., Febbraio, M., & Silverstein, R. L. (2011) · Blood · doi:10.1182/blood-2009-01-201970 · Cited by 66
Self-citationGao, D., Ashraf, M. Z., Kar, N. S., Lin, D., Sayre, L. M., & Podrez, E. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.082800 · Cited by 65
Self-citationNative high-density lipoproteins inhibit platelet activation via scavenger receptor BI
Brodde, M. F., Korporaal, S. J. A., Herminghaus, G., Fobker, M., van Berkel, T. J. C., Tietge, U. J. F., Robenek, H., Eck, M. V., Kehrel, B. E., & Nofer, J. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.12.026 · Cited by 63
Szapacs, M. E., Kim, H., Porter, N. A., & Liebler, D. C. (2008) · Journal of Proteome Research · doi:10.1021/pr8001222 · Cited by 63
Leelahavanichkul, A., Bocharov, A. V., Kurlander, R. J., Baranova, I. N., Vishnyakova, T. G., Souza, A. C. P., Hu, X., Doi, K., Vaisman, B. L., Amar, M. J., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1003445 · Cited by 65
“Thus, it was demonstrated that pathogen interaction with CD36 (17, 41, 50) directly induces JNK-dependent signaling, leading to a direct stimulation of cytokine secretion in stably transfected HEK293 cells.”
BackgroundHuang, W., Febbraio, M., & Silverstein, R. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029092 · Cited by 73
“CD36-mediated activation of platelets shares features with the macrophage pathway in that Lyn, JNK2, and Vav are all activated by CD36 in a liganddependent manner, providing a mechanistic link between oxidant stress, inflammation and thrombosis [20,21,22,23].”
BackgroundSelf-citationStellos, K., Sauter, M., Fahrleitner, M., Grimm, J., Stakos, D., Emschermann, F., Panagiota, V., Gnerlich, S., Perk, A., Schönberger, T., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.244707 · Cited by 61
Song, F., Zhu, Y., Shi, Z., Tian, J., Deng, X., Ren, J., Andrews, M. C., Ni, H., Ling, W., & Yang, Y. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-12-1002 · Cited by 68
From low-density lipoprotein to platelet activation
Akkerman, J. W. N. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.04.002 · Cited by 62
Wang, X., Fu, Y., Liu, X., Feng, G., Xiong, D., Mu, G., & Chen, F. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000494795 · Cited by 62
Ashraf, M. Z., Kar, N. S., Chen, X., Choi, J., Salomon, R. G., Febbraio, M., & Podrez, E. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710474200 · Cited by 60
Self-citationComparison of two murine models of thrombosis induced by atherosclerotic plaque injury
Hechler, B., & Gachet, C. (2011) · Thrombosis and Haemostasis · doi:10.1160/ths10-11-0730 · Cited by 63
Zhu, L., Stalker, T. J., Fong, K. P., Jiang, H., Tran, A., Crichton, I., Lee, E. K., Neeves, K. B., Maloney, S. F., Kikutani, H., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.185405 · Cited by 59
Thymidine Phosphorylase Participates in Platelet Signaling and Promotes Thrombosis
Li, W., Gigante, A. E. I., Pérez‐Pérez, M., Yue, H., Hirano, M., McIntyre, T. M., & Silverstein, R. L. (2014) · Circulation Research · doi:10.1161/circresaha.115.304591 · Cited by 62
Self-citationCD36 Signal Transduction in Metabolic Diseases: Novel Insights and Therapeutic Targeting
Karunakaran, U., Elumalai, S., Moon, J. S., & Won, K. C. (2021) · Cells · doi:10.3390/cells10071833 · Cited by 66
“Many physiological and pathological factors, such as long-chain fatty acids and proteins containing thrombospondin structural homology domains and oxidized phospholipids, including oxidized LDL (oxLDL), perturb CD36 function and induce metabolic diseases [6].”
BackgroundFeldman, C. H., & Anderson, R. (2015) · CHEST Journal · doi:10.1378/chest.15-0484 · Cited by 58
Starosta, V., Wu, T., Zimman, A., Pham, D., Tian, X., Oskolkova, O., Bochkov, V., Berliner, J. A., Birukova, A. A., & Birukov, K. G. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0153oc · Cited by 58
Lipid Oxidation and Cardiovascular Disease: Introduction to a Review Series
McIntyre, T. M., & Hazen, S. L. (2010) · Circulation Research · doi:10.1161/circresaha.110.224618 · Cited by 61
Self-citationOuweneel, A. B., & Eck, M. V. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.10.009 · Cited by 62
Platelet Proteomes, Pathways, and Phenotypes as Informants of Vascular Wellness and Disease
Aslan, J. E. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314647 · Cited by 60
CD36 in the periphery and brain synergizes in stroke injury in hyperlipidemia
Kim, E., Febbraio, M., Bao, Y., Tolhurst, A. T., Epstein, J. M., & Cho, S. (2012) · Annals of Neurology · doi:10.1002/ana.23569 · Cited by 58
Self-citationOxidized phospholipids: Biomarker for cardiovascular diseases
Ashraf, M. Z., Kar, N. S., & Podrez, E. A. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.11.002 · Cited by 59
Self-citationStübiger, G., Belgacem, O., Řehulka, P., Bicker, W., Binder, B. R., & Bochkov, V. (2010) · Analytical Chemistry · doi:10.1021/ac100280p · Cited by 56
The gut microbiota–bile acid–TGR5 axis orchestrates platelet activation and atherothrombosis
Qi, Z., Zhang, W., Zhang, P., Qu, Y., Zhong, H., Zhou, L., Zhou, W., Yang, W., Xu, H., Zhao, X., et al. (2025) · Nature Cardiovascular Research · doi:10.1038/s44161-025-00637-x · Cited by 69
Ren, B., Hale, J. S., Srikanthan, S., & Silverstein, R. L. (2011) · Blood · doi:10.1182/blood-2010-12-326017 · Cited by 55
Self-citationOxidative Phospholipidomics in health and disease: Achievements, challenges and hopes
Reis, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.014 · Cited by 56
Dietary Cholesterol Plays a Role in CD36-Mediated Atherogenesis in LDLR-Knockout Mice
Kennedy, D. J., Kuchibhotla, S. D., Guy, E., Park, Y. M., Nimako, G., Vanegas, D., Morton, R. E., & Febbraio, M. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.191940 · Cited by 54
Self-citationKanthi, Y., Hyman, M. C., Liao, H., Baek, A. E., Visovatti, S. H., Sutton, N. R., Goonewardena, S. N., Neral, M. K., Jo, H., & Pinsky, D. J. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79514 · Cited by 53
Soluble CD36− a marker of the (pathophysiological) role of CD36 in the metabolic syndrome?
Koonen, D. P. Y., Jensen, M. K., & Handberg, A. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2010.543136 · Cited by 54
“In platelets and endothelial cells CD36 functions as an adhesion molecule, and through interaction with anionic phospholipids present in, for example, oxLDL, CD36 is involved in platelet activation (Podrez et al., 2007, Valiyaveettil and Podrez, 2009).”
BackgroundExtracellular mitochondria released from traumatized brains induced platelet procoagulant activity
Zhao, Z., Zhou, Y., Hilton, T., Li, F., Han, C., Liu, L., Yuan, H., Li, Y., Xu, X. J., Wu, X., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.214932 · Cited by 53
Latchoumycandane, C., Marathe, G. K., Zhang, R., & McIntyre, T. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.300012 · Cited by 53
“Oxidatively truncated phospholipid products of these reactions accumulate in the circulation during oxidative stress (21, 22).”
BackgroundSelf-citationLow-Bone-Mass Phenotype of Deficient Mice for the Cluster of Differentiation 36 (CD36)
Kevorkova, O., Martineau, C., Martin-Falstrault, L., Sanchez-Dardon, J., Brissette, L., & Moreau, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077701 · Cited by 51
“CD36 has been implicated in platelet aggregation and thrombus formation in dyslipidemic state [21,22,23], as CD36KO mice show reduction of thrombotic vessels occlusion and aggregation of platelets in hyperlipidemic state [22].”
BackgroundDifferentiating haemostasis from thrombosis for therapeutic benefit
McFadyen, J. D., & Jackson, S. P. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-05-0379 · Cited by 60
Dooming Phagocyte Responses: Inflammatory Effects of Endogenous Oxidized Phospholipids
Gioia, M. D., & Zanoni, I. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.626842 · Cited by 53
Wang, H., Wang, Z., Kong, J., Yang, M., Jiang, G.-H., Wang, X.-P., Zhong, M., Zhang, Y., Deng, J., & Zhang, W. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00295 · Cited by 59
“CD36, a class B scavenger receptor, promotes platelet activation (10,11).”
BackgroundPathogenic Role of Scavenger Receptor CD36 in the Metabolic Syndrome and Diabetes
Kennedy, D. J., & Kashyap, S. R. (2011) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0003 · Cited by 58
Metabolomics and ischaemic heart disease
Rasmiena, A. A., Ng, T. W., & Meikle, P. J. (2012) · Clinical Science · doi:10.1042/cs20120268 · Cited by 49
Pluskota, E., Ma, Y., Bledzka, K. M., Białkowska, K., Soloviev, D. A., Szpak, D., Podrez, E. A., Fox, P. L., Hazen, S. L., Dowling, J. J., et al. (2013) · Blood · doi:10.1182/blood-2013-04-497669 · Cited by 51
“(1-363)was immobilizedon theCM5sensor chip surfaces (500RU).”
BackgroundMethodSelf-citationThrombosis in the Uremic Milieu—Emerging Role of “Thrombolome”
Shashar, M., Francis, J. M., & Chitalia, V. C. (2014) · Seminars in Dialysis · doi:10.1111/sdi.12255 · Cited by 48
“platelets to increase their adhesion and aggregation (50).”
BackgroundLDL-Cholesterol and Platelets: Insights into Their Interactions in Atherosclerosis
Gąsecka, A., Rogula, S., Szarpak, Ł., & Filipiak, K. J. (2021) · Life · doi:10.3390/life11010039 · Cited by 237
“Hence, ox-LDL binding to CD36 enables the formation of platelet-leukocyte complexes via P-selectin and cross-linking of the adjacent platelets via fibrinogen [15].”
BackgroundPetersen-Uribe, Á., Kremser, M., Rohlfing, A., Castor, T., Kolb, K., Dicenta, V., Emschermann, F., Li, B., Borst, O., Rath, D., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011179 · Cited by 49
“The interaction of oxidized low-density lipoprotein (OxLDL) via CD36 activates platelets and promotes thrombosis [7].”
BackgroundWang, W., Vootukuri, S., Meyer, A., Ahamed, J., & Coller, B. S. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303852 · Cited by 47
“by making platelets more sensitive to shear-induced activation and degranulation.(25,26) Additionally or alternatively, hypercholesterolemia may have increased release of TGF-β1 from sources other than platelets.”
BackgroundLiu, J., Chen, R., Marathe, G. K., Febbraio, M., Zou, W., & McIntyre, T. M. (2011) · Circulation Research · doi:10.1161/circresaha.110.228742 · Cited by 47
Self-citationBiswas, S., Xin, L., Panigrahi, S., Zimman, A., Wang, H., Yakubenko, V. P., Byzova, T. V., Salomon, R. G., & Podrez, E. A. (2016) · Blood · doi:10.1182/blood-2015-08-664300 · Cited by 47
“Preparation of platelets Platelet-rich plasma (PRP) and gel-filtered platelets were isolated from blood drawn from healthy human donors and mice, as described previously.(8,16)”
BackgroundMethodSelf-citationRole of Oxidized LDL in Atherosclerosis
Leiva, E., Wehinger, S., Guzmán, L., & Orrego, R. (2015) · InTech eBooks · doi:10.5772/59375 · Cited by 62
“CD36 is expressed in resting platelets and its interaction with OxLDL has been implicated with platelet activation, evidenced by P-selectin expression and the activation of integrin αIIbβ3[75].”
BackgroundMudd, J. C., Panigrahi, S., Kyi, B., Moon, S. H., Manion, M. M., Younes, S., Sieg, S. F., Funderburg, N., Zidar, D. A., Lederman, M. M., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw463 · Cited by 48
“Platelet Assays Platelets were isolated as described previously [23].”
MethodRedox Mechanisms in Migraine: Novel Therapeutics and Dietary Interventions
Ferroni, P., Barbanti, P., Della‐Morte, D., Palmirotta, R., Jirillo, E., & Guadagni, F. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7260 · Cited by 57
“Apart from antioxidant enzymes, platelets also express scavenger receptors, such as CD36 (238), which might serve as a sensor of specific oxidized phospholipids generated during oxidative stress (288).”
Palanisamy, G. S., Kirk, N. M., Ackart, D. F., Obregón‐Henao, A., Shanley, C. A., Orme, I. M., & Basaraba, R. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034148 · Cited by 47
“Increased CD36 receptor expression by platelets has been shown to be prothrombotic in several mouse models of microvascular thrombosis [37].”
BackgroundScavenger receptors: Implications in atherothrombotic disorders
Ashraf, M. Z., & Gupta, N. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.01.019 · Cited by 50
Yin, H., Cox, B. E., Liu, W., Porter, N. A., Morrow, J. D., & Milne, G. L. (2009) · Journal of Mass Spectrometry · doi:10.1002/jms.1542 · Cited by 44
“[3,10–13] A number of oxidation products have been identified by a variety of MS methods and isoprostanes (IsoPs), isomers of prostaglandins, are one of the major oxidation products.”
BackgroundCellular phospholipid uptake: Flexible paths to coregulate the functions of intracellular lipids
Engelmann, B., & Wiedmann, M. K. H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.02.013 · Cited by 42
Li, D., Xie, P., Zhao, S., Zhao, J., Yao, Y., Zhao, Y., Ren, G., & Liu, X. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.02.124 · Cited by 45
Cammisotto, V., Baratta, F., Castellani, V., Bartimoccia, S., Nocella, C., D’Erasmo, L., Cocomello, N., Barale, C., Scicali, R., Di Pino, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137193 · Cited by 42
“LDL oxidation plays a critical role in PA [18] by binding specific receptors on platelet surface, namely, CD36 and LOX1 [18,19].”
BackgroundInfluentialDiaz, J. A., Ballard-Lipka, N., Farris, D. M., Hawley, A. E., Wrobleski, S. K., Myers, D. D., Henke, P. K., Lawrence, D. A., & Wakefield, T. W. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.08.038 · Cited by 41
Role of multiligand/RAGE axis in platelet activation
Fuentes, E., Rojas, A., & Palomo, I. F. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.11.007 · Cited by 46
“Interactions of platelet CD36 with specific endogenous oxidized lipids play a crucial role in the well-known clinical associations between dyslipidemia, oxidant stress and a prothrombotic phenotype [75,76].”
BackgroundNkambule, B. B., Davison, G. M., & Ipp, H. (2015) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1212-8 · Cited by 40
Cammisotto, V., Baratta, F., Simeone, P., Barale, C., Lupia, E., Galardo, G., Santilli, F., Russo, I., & Pignatelli, P. (2022) · Antioxidants · doi:10.3390/antiox11030569 · Cited by 42
“LOX1 expression is atheroma-related and not native and, like CD36, its interaction with ox-LDL induces platelet activation and aggregation, contributing to thrombus formation [39].”
BackgroundInfluential
Metadata
- Authors
- Podrez, E. A., Byzova, T. V., Febbraio, M., Salomon, R. G., Ma, Y., Valiyaveettil, M., Poliakov, E., Sun, M., Finton, P. J., Curtis, B. R., Chen, J., Zhang, R., Silverstein, R. L., & Hazen, S. L.
- Affiliations
- Cleveland Clinic (US)
- Case Western Reserve University (US)
- Versiti Blood Center of Wisconsin (US)
- Corresponding author
- Podrez, Eugene A
- ORCID
- Venue
- Nature Medicine
- Published
- 2007-08-26
- Volume
- 13
- Issue
- 9
- Pages
- 1086-1095
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC3042888
- OpenAlex
- W2029684068
- Cited by
- 513
- References
- 47
- Citations by year
- 2026: 25 · 2025: 24 · 2024: 18 · 2023: 29 · 2022: 32 · 2021: 27 · 2020: 27 · 2019: 25 · 2018: 23 · 2017: 24 · 2016: 16 · 2015: 27 · 2014: 26 · 2013: 28 · 2012: 36
- FWCI
- 19.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL071625., P01HL046403, HL053315, HL 073311, HL076491, HL-072942, R01HL070083, P50 HL-81011, HL077107, HL077213, P01HL072942, P50HL077107, P01HL077107, R01HL077213, P01HL076491, HL 70621, HL70083, R01HL053315, HL-46403, P01HL073311, R01HL070621, P50HL081011, R01HL071625)
- National Center for Research Resources (M01RR018390)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- hyperlipidemia, oxidative stress, prothrombotic phenotype, oxidized lipids, platelet activation, scavenger receptors, dyslipidemia, thrombosis, HDL cholesterol
- MeSH terms
- Animals, Blood Platelets, Humans, Hyperlipidemias, Male, Phenotype, Phospholipids, Prothrombin, Thrombosis, Platelet Activation, Antigens, CD, Gene Deletion, Mice, Knockout, Oxidative Stress, CD36 Antigens, Dyslipidemias, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.